News + Filings Holdings
|
Bellevue Group AG
> ESPR
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Esperion Therapeutics, Inc. | ESPR | 4,208,264 | 0 | 5,849,487,000 | -841,653,000 | $1,390.00 |
| 03/31/2023 | Esperion Therapeutics, Inc. | ESPR | 4,208,264 | -122,000 | 6,691,140,000 | -20,286,405,000 | $1,590.00 |
| 12/31/2022 | Esperion Therapeutics, Inc. | ESPR | 4,330,264 | 105,000 | 26,977,545,000 | 26,949,236,000 | $6,230.00 |
| 09/30/2022 | Esperion Therapeutics, Inc. | ESPR | 4,225,264 | -10,000 | 28,309,000 | 1,373,000 | $6.70 |
| 06/30/2022 | Esperion Therapeutics, Inc. | ESPR | 4,235,264 | -63,900 | 26,936,000 | 6,988,000 | $6.36 |
| 03/31/2022 | Esperion Therapeutics, Inc. | ESPR | 4,299,164 | -220,000 | 19,948,000 | -2,648,000 | $4.64 |
| 12/31/2021 | Esperion Therapeutics, Inc. | ESPR | 4,519,164 | 0 | 22,596,000 | -31,859,000 | $5.00 |
| 09/30/2021 | Esperion Therapeutics, Inc. | ESPR | 4,519,164 | 0 | 54,455,000 | -41,125,000 | $12.05 |
| 06/30/2021 | Esperion Therapeutics, Inc. | ESPR | 4,519,164 | 530,000 | 95,580,000 | -16,316,000 | $21.15 |
| 03/31/2021 | Esperion Therapeutics, Inc. | ESPR | 3,989,164 | -1,149,287 | 111,896,000 | -21,703,000 | $28.05 |
| 12/31/2020 | Esperion Therapeutics, Inc. | ESPR | 5,138,451 | -327,264 | 133,599,000 | -69,561,000 | $26.00 |
| 09/30/2020 | Esperion Therapeutics, Inc. | ESPR | 5,465,715 | 162,580 | 203,160,000 | -68,944,000 | $37.17 |
| 06/30/2020 | Esperion Therapeutics, Inc. | ESPR | 5,303,135 | 265,245 | 272,104,000 | 113,260,000 | $51.31 |
| 03/31/2020 | Esperion Therapeutics, Inc. | ESPR | 5,037,890 | 512,880 | 158,844,000 | -110,982,000 | $31.53 |
| 12/31/2019 | Esperion Therapeutics, Inc. | ESPR | 4,525,010 | 283,549 | 269,826,000 | 114,334,000 | $59.63 |
| 09/30/2019 | Esperion Therapeutics, Inc. | ESPR | 4,241,461 | 184,050 | 155,492,000 | -33,258,000 | $36.66 |
| 06/30/2019 | Esperion Therapeutics, Inc. | ESPR | 4,057,411 | 3,561,864 | 188,750,000 | 168,854,000 | $46.52 |
| 03/31/2019 | Esperion Therapeutics, Inc. | ESPR | 495,547 | 43,575 | 19,896,000 | -895,000 | $40.15 |
| 12/31/2018 | Esperion Therapeutics, Inc. | ESPR | 451,972 | 60,120 | 20,791,000 | 3,405,000 | $46.00 |
| 09/30/2018 | Esperion Therapeutics, Inc. | ESPR | 391,852 | 78,332 | 17,386,000 | 5,099,000 | $44.37 |
| 06/30/2018 | Esperion Therapeutics, Inc. | ESPR | 313,520 | 140,800 | 12,287,000 | -206,000 | $39.19 |
| 03/31/2018 | Esperion Therapeutics, Inc. | ESPR | 172,720 | 164,920 | 12,493,000 | 11,979,000 | $72.33 |
| 12/31/2017 | Esperion Therapeutics, Inc. | ESPR | 7,800 | -200 | 514,000 | 113,000 | $65.90 |
| 09/30/2017 | Esperion Therapeutics, Inc. | ESPR | 8,000 | 0 | 401,000 | 31,000 | $50.13 |
| 06/30/2017 | Esperion Therapeutics, Inc. | ESPR | 8,000 | -24,000 | 370,000 | -760,000 | $46.25 |
| 03/31/2017 | Esperion Therapeutics, Inc. | ESPR | 32,000 | -8,000 | 1,130,000 | 629,000 | $35.31 |
| 12/31/2016 | Esperion Therapeutics, Inc. | ESPR | 40,000 | 0 | 501,000 | -53,000 | $12.53 |
| 09/30/2016 | Esperion Therapeutics, Inc. | ESPR | 40,000 | 0 | 554,000 | 159,000 | $13.85 |
| 06/30/2016 | Esperion Therapeutics, Inc. | ESPR | 40,000 | 0 | 395,000 | -281,000 | $9.88 |
| 03/31/2016 | Esperion Therapeutics, Inc. | ESPR | 40,000 | 40,000 | 676,000 | 676,000 | $16.90 |
| << Prev Next >> |
|